Aarti Drugs Ltd - Shs Dematerialised

BOM:524348 (India)   Shs Dematerialised
₹ 511.30 (+3.73%) Jun 7
25.90
P/B:
3.46
Market Cap:
₹ 47.01B ($ 562.77M)
Enterprise V:
₹ 52.44B ($ 627.84M)
Volume:
38.94K
Avg Vol (2M):
14.16K
Volume:
38.94K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Aarti Drugs Ltd ( ) from 1993 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Aarti Drugs stock (BOM:524348) PE ratio as of Jun 07 2024 is 25.9. More Details

Aarti Drugs Ltd (BOM:524348) PE Ratio (TTM) Chart

To

Aarti Drugs Ltd (BOM:524348) PE Ratio (TTM) Historical Data

Total 1247
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Aarti Drugs PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-08 27.5 2024-04-01 24.6
2024-06-07 27.5 2024-03-28 23.3
2024-06-06 26.5 2024-03-27 22.6
2024-06-05 25.9 2024-03-26 22.7
2024-06-04 25.6 2024-03-22 23.4
2024-06-03 26.2 2024-03-21 22.9
2024-05-31 25.6 2024-03-20 22.5
2024-05-29 26.1 2024-03-19 22.9
2024-05-28 26.6 2024-03-18 23.2
2024-05-27 25.9 2024-03-14 23.5
2024-05-24 26.4 2024-03-13 23.2
2024-05-23 26.4 2024-03-12 23.6
2024-05-22 26.6 2024-03-11 23.8
2024-05-21 26.6 2024-03-07 24.4
2024-05-17 26.4 2024-03-06 24.7
2024-05-16 26.1 2024-03-05 25.1
2024-05-15 25.8 2024-03-04 25.5
2024-05-14 25.5 2024-03-01 25.8
2024-05-13 25.4 2024-02-29 25.5
2024-05-10 24.9 2024-02-28 25.6
2024-05-09 24.6 2024-02-27 26.4
2024-05-08 25.5 2024-02-26 26.3
2024-05-07 25.6 2024-02-23 27.2
2024-05-06 26.4 2024-02-22 27.5
2024-05-03 27.0 2024-02-21 27.2
2024-05-02 26.9 2024-02-20 27.9
2024-04-30 27.1 2024-02-19 27.8
2024-04-29 27.3 2024-02-16 27.1
2024-04-26 27.1 2024-02-15 27.4
2024-04-25 26.9 2024-02-14 27.4
2024-04-24 27.0 2024-02-13 27.1
2024-04-23 26.9 2024-02-12 26.9
2024-04-22 26.5 2024-02-09 27.3
2024-04-19 26.7 2024-02-08 27.4
2024-04-18 26.5 2024-02-07 27.3
2024-04-16 26.6 2024-02-06 27.6
2024-04-15 26.4 2024-02-05 26.7
2024-04-12 27.1 2024-02-02 26.1
2024-04-10 27.4 2024-02-01 27.1
2024-04-09 27.6 2024-01-31 27.0
2024-04-08 26.2 2024-01-30 26.4
2024-04-05 26.5 2024-01-29 25.9
2024-04-04 26.2 2024-01-25 25.8
2024-04-03 25.5 2024-01-24 27.4
2024-04-02 25.1 2024-01-23 27.4

Aarti Drugs Ltd (BOM:524348) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.